Dexamethasone Eye Drops to Prevent Treatment-Requiring Retinopathy of Prematurity: The DROPROP Randomized Clinical Trial.
The DROPROP double-masked, multicentre randomised clinical trial tested whether topical dexamethasone could prevent progression to treatment-requiring type 1 retinopathy of prematurity (ROP) in preterm infants born…
Why it matters
Treatment-requiring ROP currently calls for invasive interventions intended to prevent blindness. A topical approach could offer a less invasive means of reducing progression in preterm infants, but this trial’s…